Aurinia pharmaceuticals inc

Major-Pharmaceuticals

AUPH


4464 Markham Street
Victoria , BC V8Z 7X8

Executive/
Director

Price

  • Last Close
  • $ 10.43
    $ +1.3 14.18 %
    Dec 10, 2024
  • 52-Week High/Low
  • $10.19 - $4.81
  • YTD
  • 16%

  • Trading Volume
  • 243,037
  • Market Cap Full
  • $ 1.5B
  • Shares Outstanding
  • 143.6M
    Nov 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 19.8% 17.8% 249.5% 14.6% -4.7% -5% -4.2% -45.9% 153.7% -44.3%
Q2 -30.7% -4.8% -16.5% 11.3% -3.8% 4% -0.2% -18.8% -11.7% -5.9%
Q3 -6% 8.7% 2.3% 19.6% -19.4% 8% 70.8% -25.2% -19.7% -
Q4 -13% -30.2% -32.5% 8.8% 283.8% -7.6% 3.3% -42.6% 20.8% -
J F M A M J J A S O N D
2024 -16.1% -24.1% -12.4% 1.4% - - - - - - - -
2023 109.5% 0.4% 20.6% 2.7% -20.4% 8% 19.6% -21.7% -14.3% -5.5% 17.7% 4.1%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%-32%-15%116%51%199%-33%69%-81%108%16%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.27 0.13 0.20 -0.18 -0.14 -0.15 -0.4 -0.27 -0.18
Q2 0.02 0.14 0.03 -0.19 -0.17 -0.26 -0.37 -0.25 -0.08
Q3 0.18 0.19 0.16 -0.21 -0.21 -0.28 -0.39 -0.06 -0.09
Q4 0.16 0.22 0.04 -0.18 -0.81 -0.1 -0.24 -0.18 -
A 0.6 0.7 0.4 -0.8 -1 -0.9 -1.4 -0.8 -0.35

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2021 2022 2023
Mar - - 127.5 141.7 142.6
Jun - - 128.2 141.7 143
Sep - - 128.4 141.9 143.4
Dec 85.5 111.8 129.7 142.1 143.6

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.2 0.1 - - -
Fixed Asset Turnover 7.9 2.9 1.7 - -
Total Asset Turnover 0.3 0.1 0.1 - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 22.6 -180 -16.2 -1.6 -7
Equity multiplier - - 0.1 - -